Replies to post #13198 on Oncolix Inc. (fka ONCX)

[dabullishbear]

Great post. Deserves a sticky.

[tmcfo]

Great post...clearly explained that even a novice should understand..

[namtae]

A lot of this would be accurate if not for the fact its 100% BS

[namtae]

So, lets provide some valid information before someone falls for that BS

The shares that you are referring to are going to be restricted for at least one year. Those shares will belong to the private equity interest holders of the (then) private company Oncolix.

WRONG!! The sole purpose of the S-1 (and all S-1's) is to register shares for sale. Just the OPPOSITE of them being restricted lol

Those shareholders are a collection of accredited investors who represent endowments, trusts, institutional investors and high net worth individuals

.

Who cares? Thats not a catalyst to absorb up to 126,000,000 new shares

The only shares that will be hitting the public float anytime soon, are the interest payments on the note recently issued.
They are two separate things.

WRONG!! Those interest payments are made in CASH until such time the S-1 goes effective. The deal is interest payments can be made in shares but only in FREE TRADING shares.

The $4M note has interest payments due @ 10% annum.

A $4M note, due interest annually is $400,000. That makes for a quarterly interest payment of $100,000 that the company has the option to deliver in the form of cash or shares.

WRONG!! See above

Yes, there is some equity due along with interest, but the terms negotiated by Oncolix make those conditions at the discrepancy of the company and the holder.

First off, it cant be at the discretion of BOTH the company and the holder. If both have discretion then neither do lol. Second, the rest doesnt make any sense

Those are the only shares that could possibly hit the float anytime soon. I consider those shares to be largely irrelevant given the AEPP share structure and public float.

WRONG!! A significant amount of the 126,000,000 shs being registered will immediately be included into the public float upon effectiveness of the S-1

While some claim that AEPP is illiquid, we could also say that it is thinly traded. Both statements would be correct. It just depends on how you want to frame it.

Either way equals volatility upon news, good or bad.

The fact shares are illiquid or thinly traded is precisely the CONCERN when SUPPLY (up to 126m) overwhelms DEMAND

We already know that some brokers and third party market data providers show the name change, while others do not.

Sorry, but a name change is not a catalyst for anything, let alone absorbing up to 126m shares lol

As some have stated here already, Oncolix has already received the new cusip number. We are just waiting for FINRA internal system changes.

Sorry, but a new cusip is not a catalyst for anything, let alone absorbing up to 126m shares lol

Once the FINRA change is announced, all brokers and market providers will be providing updates in a timely and uniform fashion.

Sorry, but the FINRA change is not a catalyst for anything, let alone absorbing up to 126m shares lol

The Oncolix SEC CIK# has already been documented and linked to.

Meaningless

The FINRA internal system change is the first FLE event that could have a positive impact on the stock.

The impact is as meaningless as the other events mentioned

The second would be the appointment of a few credible independent BOD members.

New board members will mean nothing to Oncolix shares. Are there multiple examples of OTC companies adding a board member which immediately resulted in a massive spike in buying that would absorb up to 126m new shares? lol

The third would be the re-instatement of our OTCQB tier.

QB could ease restrictions for a handful of otc brokers, if they were interested in purchasing a limited amount of shares... but unlikely

The fourth would be any S-1s and S-1As showing progress on the eventual goal of a certnas/certnyse filing that would lead to being listed on the NASDAQ or NYSE.

S-1's are not filed to show progress or decline or to uplist. The primary purpose of an S-1 is to REGISTER SECURITIES for sale lol

The fifth would be any progress regarding the advancement of FDA clinical trials.

As mentioned previously, its highly unlikely Oncolix even restarts its P1 study until Q2 2018, at the earliest, let alone providing any results. This S-1 will be effective long before that.

The sixth would be the addition of any other endowments, trusts or institutional investment.

As can be seen in Aug 2017, the investments made in Oncolix are of the TOXIC variety, which is the main reason up to 126m new shares will be added to the float. Until such time more traditional sources of funding are available, further investment = further toxicity/dilution

The seventh would be the announcement any additional grants from either the US government or the Susan G. Komen foundation. Both have provided grants for prolactin research in the past.

Wishful thinking isnt reality. Catalysts need to be defined and tangible or likely over the course of the next month or so. They also have to be realistic with some degree of evidence to corroborate.

Also keep in mind grants are for specific purposes and may not further Oncolixs primary objectives

[namtae]

The shares that you are referring to are going to be restricted for at least one year. Those shares will belong to the private equity interest holders of the (then) private company Oncolix.

Completely WRONG - they will be available for sale once the S-1 goes effective... Strike 1

The only shares that will be hitting the public float anytime soon, are the interest payments on the note recently issued.
They are two separate things.

Completely WRONG - the one interest payment due Nov 1 had to be paid in cash since the S-1 hasnt gone effective yet. The only option to pay in shares are in free trading shares

A $4M note, due interest annually is $400,000. That makes for a quarterly interest payment of $100,000 that the company has the option to deliver in the form of cash or shares.

Completely WRONG - the company DOES NOT have the option to pay in shares until the shares are free trading... which means that option isnt available at this time

Those are the only shares that could possibly hit the float anytime soon. I consider those shares to be largely irrelevant given the AEPP share structure and public float

.

Those share interest payments would have equated to appx 2,000,000 shares which if dumped into the market of a stock trading as thinly as AEPP, would hammer it down... in addition, the S-1 can go effective at any time which creates in the aaggrega

[namtae]

complete BS

[namtae]

Shouldnt sticky posts contain accurate information?

The shares that you are referring to are going to be restricted for at least one year. Those shares will belong to the private equity interest holders of the (then) private company Oncolix.

WRONG - they will be available for sale once the S-1 goes effective...which can be at any time, theres no rule when. Strike 1

The only shares that will be hitting the public float anytime soon, are the interest payments on the note recently issued.
They are two separate things.

Glad to see this admission that the only shares hitting the float anytime soon would be the interest payment shares. See, the only way that happens is once the S-1 goes effective because AEPP can only make interest payments in shares if they are FREE TRADING.. for that to happen, the S-1 must go effective soon, along with the rest of the 126m shares...contradicting claims those 126m shs wont be available anytime soon lol...Strike 2

Those are the only shares that could possibly hit the float anytime soon. I consider those shares to be largely irrelevant given the AEPP share structure and public float

.

WRONG - Those interest payments in shares would have equated to appx 2,000,000 shares which if dumped into the market of a stock trading as thinly as AEPP, would hammer it down... in addition, the S-1 can go effective at any time which creates up to 126m shares instantly available for sale..oh yea, this repeats itself MONTHLY!! Strike 3

While some claim that AEPP is illiquid, we could also say that it is thinly traded. Both statements would be correct. It just depends on how you want to frame it.

Either way equals volatility upon news, good or bad.

WRONG - theres no "either way" here. When AEPP has 126m new shares registered for SALE - its not counterbalanced with 126m shares of buyers waiting on the sidelines lol Its a simple supply/demand issue. Huge supply vs very little demand

The fourth would be any S-1s and S-1As showing progress on the eventual goal of a certnas/certnyse filing that would lead to being listed on the NASDAQ or NYSE

.

As was corrected previously, S-1's are forms used primarily to register shares for sale, not report progress lol

Thats about enough...

Most all the catalysts mentioned are ridiculous.. QB and cusip#s will have ZERO impact.. a company changes its symbol, therefore its more valuable hahahaha

The rest can be found in previous responses... so take down the full of BS sticky post asap...thanks